Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - TOTAL EQUITY
Total Equity TRVI - Trevi Therapeutics, Inc.
82.5 M
LAST VALUE
119.87%
2 YEAR CAGR
36.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR